Does the wellness focus of Prysm iO broaden the sales leader profile or shift the focus for existing beauty-oriented sales leaders?

There is a learning curve for beauty consultants to adapt to selling wellness products and building networks around them. While beauty and wellness have long-term synergies, the near-term challenge is orienting existing salespeople to effectively sell wellness and Prysm iO. “there is a learning curve for those beauty consultants or affiliates to really learn how to -- not only how to explain a wellness product for themselves, but also how to then sell it and build a network or a sales team around that.”

Q4 guidance implies strong adjusted EPS. Besides Prysm iO devices, what other factors could drive the higher or lower end of guidance?

Key drivers for H2 include continued interest in Prysm iO, the global live event in Japan (aligning 10,000+ leaders on Prysm iO, AI app, and new science), and Q4 being a strong promotional quarter with Black Friday and holiday sales, particularly in the East. “coming out of the live event, this is really our opportunity. It happens only once every couple of years where we're able to really sit down and align with our leadership around the globe, deeper than just our top-tier leaders.”

NUS

Nu Skin (NUS) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Consumer Staples· Aug 10, 2026

Source: earnings call transcript

Executive summary

Nu Skin Q2 FY26 — Prysm iO Rollout Progresses, India Launch Delayed, and Profitability Focus

Nu Skin's second quarter saw continued progress in the global rollout of its Prysm iO intelligent anti-aging platform, with significant increases in device placements and scans, though initial usage patterns differed from expectations. The company maintained a focus on profitability, achieving adjusted EPS near guidance, but faced headwinds from foreign currency and non-cash impairment charges. Strategic priorities include refining the sales force compensation, optimizing the operating model, and delaying the India market launch to ensure long-term success.

Highlights

Prysm iO device placements increased by nearly 30% quarter-over-quarter to over 39,000 devices.
Prysm iO scans increased by 25% quarter-over-quarter to 2.5 million.
Adjusted EPS of $0.20 was near the midpoint of the previously communicated range.
Core Nu Skin gross margin improved to 77.7%, up 20 basis points from the prior year.
General and administrative expenses declined by $15.9 million year-over-year.

Concerns

Revenue of $320.1 million included an approximate 1% or $4 million foreign currency headwind.
Reported EPS was negative $5.14 due to a $78.9 million non-cash goodwill impairment and a $167.5 million non-cash deferred tax valuation allowance.
India's formal market launch was moved to the first half of 2027 to refine the business model and ensure readiness.
Recruiting and leadership development remain below the levels needed to return the business to sustainable growth.
Adjusted operating margin for the quarter was 6.1%, down from 8% in the prior year.

Guidance & targets

Category	Target	Timeline	Confidence
Q3 Revenue	$310 million to $340 million high materiality	Q3 · FY26	High
Q3 Adjusted EPS	$0.10 to $0.20 high materiality	Q3 · FY26	High
Full-year 2026 Revenue	$1.28 billion to $1.35 billion high materiality	FY26	High
Full-year 2026 Adjusted EPS	$0.70 to $0.90 high materiality	FY26	High
Prysm iO devices placed	50,000 to 60,000 medium materiality	FY26	Medium
Long-term core business gross margin	approximately 80% medium materiality	Long-term	Medium
Organizational transition costs	$5 million to $10 million medium materiality	H2 FY26	High
Full-year 2026 Adjusted Effective Tax Rate	approximately 35% medium materiality	FY26	High
India formal market launch	First half of 2027 high materiality	H1 FY27	High

Product announcements

Product	Type	Timeline	Details
AI-enabled Prysm iO app	launch	September (at global live event in Japan)
New range of products to support women's unique health needs	launch	at global live event in Japan

Risks & headwinds

Foreign currency headwind Q2 FY26

approximate 1% or $4 million impact on Q2 revenue

Mitigation:Not explicitly stated, but ongoing focus on profitability and cost optimization.

Non-cash goodwill impairment charge Q2 FY26

$78.9 million

Mitigation:Related to Rhyz manufacturing reporting unit, excluded from adjusted results as not indicative of ongoing operating performance.

Non-cash valuation allowance on U.S. deferred tax assets Q2 FY26

$167.5 million

Mitigation:Resulted from reassessment due to goodwill impairment, excluded from adjusted results.

Difficult operating environment Ongoing

Not quantified, but impacts sales force resilience.

Mitigation:Redesigning compensation framework, new leadership achievement roadmap, increased investments in leadership achievements.

Recruiting and leadership development below levels needed for sustainable growth Ongoing

Not quantified, but impacts business growth.

Mitigation:Redesigning global compensation framework, introducing new leadership achievement roadmap, increased investments in leadership achievements.

Mixed macroeconomic environment in Latin America Ongoing

Not quantified

Mitigation:Leaders demonstrating strong commitment and resilience.

What to watch in Q3 FY26

India formal market launch

Next quarter (leading up to H1 2027)

Current Moved to H1 2027

Target Progress on business model refinement and operational readiness

Why it matters

India represents a significant long-term growth opportunity, and successful optimization of the business model is crucial for sustainable scaling.

And as a result, we've decided to move our full market launch into the first half of 2027 to ensure business model, operational and field readiness for the significant long-term opportunity.

Find out whether NUS delivers this. Inve re-checks your case every morning.

Q&A highlights

What specific learnings led to the India launch delay, and what are the expected benefits of pushing it back?

The delay allows for refinement of the business model to ensure Nu Skin's quality standards with local manufacturing, optimize logistics, integrate technology with local systems, and adapt the business model to local commercial practices for better network building. The goal is a more effective and sustainable long-term launch in H1 2027.

“What we want to do as we evaluate the model moving forward is to ensure that the actual business model, in other words, how our affiliates will grow the business in India based upon our first 6 or 7 months of learning that we optimize in order to enable better network building capabilities in the market.”

asked by Dave Storms · answered by Ryan Napierski

2 min read 6 chapters

Detailed narrative

Prysm iO Platform Evolution

Nu Skin's next-gen anti-aging innovation, Prysm iO, has seen over 39,000 devices placed and 2.5 million scans, growing 30% and 25% QoQ respectively. Initial insights show sales leaders primarily use it as a wellness consultation tool rather than an in-home placement device, informing a refined commercial strategy.

The company aims for 50,000 to 60,000 devices by year-end and will introduce an AI-enabled app in September for personalized assessments and plans.

Strategic Sales Force Empowerment

The company is redesigning its global compensation framework to balance product selling, team building, and leadership development, with rollouts in Americas and Pacific in H1 2026 and other markets through 2027. A new leadership achievement roadmap will be introduced in the fall to provide clearer developmental pathways and stronger incentives, accompanied by increased investments in leadership achievements.

India Market Launch Refinement

The formal launch in India has been moved to the first half of 2027. This delay is intentional, allowing for optimization of local product sourcing, logistics partnerships, technology integration, and refinement of the business model to better suit local commercial practices and enable more effective network building. The company believes this will position them for stronger, more sustainable growth.

Profitability and Operational Efficiency

Nu Skin is focused on improving profitability through thoughtful price actions, supply chain efficiencies, and infrastructure improvements, targeting an 80% long-term gross margin in its core business. This includes strategic price increases and realigning manufacturing facilities to serve East and West markets more efficiently.

East-West Operating Model Transition

To better support distinct market approaches, Nu Skin is transitioning from a 7-region structure to an East-West operating model over the next two quarters. This aims to create a more agile, efficient, and growth-oriented organization, expected to generate meaningful cost savings starting in H2 2026 with larger benefits in 2027, alongside $5 million to $10 million in cash-based organizational transition costs.

Anti-Aging Research and Innovation

Building on nearly two decades of ageLOC science, Nu Skin is expanding its understanding of biological aging through new research and collaborations, informing its "aging response modulator science." This approach, incorporating epigenetics, is expected to fuel future innovations. Two new products supporting women's health needs will be introduced at the global live event in Japan.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.